Symposium:
180. From Pathogenesis to Clinical Aspects of Infections Caused by Non-Tuberculosis Mycobacteria
Saturday, October 22, 2011: 5:15 PM-6:45 PM
Room: 205ABC

Learning Objectives:

The pathogenesis of NTM infection is being dissected at a rapid rate and this is the chance to explore the host and pathogen together. At the completion of this session, participants will be able to:

  • recognize the role of biofilms in NTM pathogenesis
  • recognize the known defects, immune and epithelial, that predispose to NTM infection
  • identify some of the newer treatments being used and proposed

Target Audience: Scientists, Researchers, Public Health Practitioners, Pharmacists, Microbiologists, Infectious Diseases Physicians, Epidemiologists, Clinicians, Academicians

Tracks: Investigative ID, HIV, Pediatric ID, Adult ID

Moderators:  Luiz Bermudez, MD, Oregon State University and Steven Holland, MD, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Presentations:

5:15 PM

5:35 PM
NTM Interaction with the Host
Luiz Bermudez, MD

5:55 PM
Clinical Insights into NTM Lung Disease
Kenneth Olivier, MD, MPH

6:15 PM
Drugs for NTM and Management
Richard Wallace, MD, FIDSA

CME Credits: Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-082-L01-P

Disclosures:

L. Bermudez, None

S. Holland, None

M. Behr, None

L. Bermudez, None

K. Olivier, Insmed, Inc: Investigator, Research support

R. Wallace, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.